Theradiag Logo

Theradiag

ISIN: FR0004197747 | Ticker: ALTER | LEI: 969500CDG241WHIFL611
Sector: Health CareSub-Industry: Biotechnology
Country: France

About Theradiag

Company Description

Established on the diagnostics market for 30 years, Theradiag is now recognized as a key player in the development, manufacturing and marketing of innovative in-vitro diagnostic products, but also as a pioneer in Theranostics. This extensive experience in the field of diagnostics, combined with the reliability of our products and the performance of our customer service, enable us to address biologists as a high-quality partner with ISO 13 485 certifications.

Present in more than 70 countries, through its in vitro diagnostic activities and benefiting from strong growth in Theranostics, Theradiag brings together a whole range of unique and innovative skills to provide a personalized response to each of its customers, biologists and clinicians. Theradiag is a leader in Theranostics and in the monitoring of autoimmune diseases, which is the third leading cause of morbidity in the world.

Year founded

1986

Served area

Worldwide

Headcount

59

Headquarters

14 Rue Ambroise Croizat, 77183 Croissy-Beaubourg – France

Filings & Publications

Sign up and we will give you access!

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

FR0004197747

LEI

969500CDG241WHIFL611

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Euronext Paris

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.